<p>Privia Health Group, Inc. (NASDAQ:PRVA - 獲取免費報告) 的股價在週四的交易中創下了新的 52 周高點。該股最高交易價格為 26.51 美元，最後交易價格為 26.02 美元，交易量為 83139 股。該股此前收盤價為 25.02 美元。</p>
<p>獲取 <strong>Privia Health Group</strong> 的提醒：</p>
<h2>分析師評級變動</h2>
<p>PRVA 最近受到多份分析師報告的關注。巴克萊將 Privia Health Group 的目標價從 21.00 美元上調至 22.00 美元，並在 10 月 9 日的研究報告中給予該股 “持平” 評級。Zacks Research 在 8 月 19 日的研究報告中將 Privia Health Group 的評級從 “強烈賣出” 上調至 “持有”。花旗在 8 月 29 日的研究報告中重申了對 Privia Health Group 股票的 “跑贏大盤” 評級。Evercore ISI 在 7 月 9 日的研究報告中將 Privia Health Group 的目標價從 30.00 美元下調至 28.00 美元，並給予該公司 “跑贏大盤” 評級。最後，Piper Sandler 在 8 月 11 日的報告中將 Privia Health Group 的目標價從 36.00 美元下調至 35.00 美元，並對該股給予 “增持” 評級。共有 11 位研究分析師對該股給予 “買入” 評級，2 位給予 “持有” 評級，1 位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，共識目標價為 28.91 美元。</p>
<p><strong>閲讀我們對 PRVA 的最新分析</strong></p>
<h2>Privia Health Group 股票表現</h2>
<p>該股的 50 日移動平均線為 24.10 美元，200 日移動平均線為 22.76 美元。該公司的市值為 31.8 億美元，市盈率為 236.70，PEG 比率為 3.37，貝塔值為 0.83。</p>
<p>Privia Health Group (NASDAQ:PRVA - 獲取免費報告) 最近於 6 月 7 日發佈了其財報。該公司報告季度每股收益（EPS）為 0.10 美元。該季度的收入為 2.1361 億美元。Privia Health Group 的股本回報率為 2.13%，淨利潤率為 0.78%。研究分析師平均預計 Privia Health Group, Inc.在當前年度將發佈 0.14 美元的每股收益。</p>
<h2>機構投資者對 Privia Health Group 的看法</h2>
<p>幾家對沖基金最近買入和賣出了該股的股份。Smartleaf Asset Management LLC 在第三季度將其在 Privia Health Group 的持股增加了 37.4%。Smartleaf Asset Management LLC 目前擁有該公司價值 303,000 美元的 12,398 股股票，在上個季度額外購買了 3,373 股。Van Berkom &amp; Associates Inc.在第三季度將其在 Privia Health Group 的持股增加了 30.1%。Van Berkom &amp; Associates Inc.目前擁有該公司價值 93,987,000 美元的 3,774,565 股股票，在此期間額外購買了 873,344 股。Thrivent Financial for Lutherans 在第三季度將其在 Privia Health Group 的持股增加了 8.0%。Thrivent Financial for Lutherans 目前擁有該公司價值 2,072,000 美元的 83,229 股股票，在此期間額外購買了 6,130 股。亞利桑那州退休系統在第三季度將其在 Privia Health Group 的持股增加了 1.9%。亞利桑那州退休系統目前擁有該公司價值 718,000 美元的 28,835 股股票，在上個季度額外購買了 524 股。最後，Summit Global Investments 在第三季度將其在 Privia Health Group 的持股增加了 273.9%。Summit Global Investments 目前擁有該公司價值 839,000 美元的 33,677 股股票，在上個季度額外購買了 24,670 股。94.48% 的股票目前由機構投資者和對沖基金持有。</p>
<h2>關於 Privia Health Group</h2>
<p>(獲取免費報告)</p>
<p>Privia Health Group, Inc. 是一家在美國運營的全國性醫生賦能公司。該公司與醫療集團、健康計劃和健康系統合作，以優化醫生的實踐，提升患者體驗，並獎勵醫生在面對面和虛擬環境中提供護理。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票比 Privia Health Group 更好</li>
<li>投資於高市盈率成長股</li>
<li>Dutch Bros 連續第 11 個季度超出預期</li>
<li>股票平均計算器</li>
<li>從分紅到增長：為什麼這三隻股票在 2025 年脱穎而出</li>
<li>股票情緒分析：它是如何工作的</li>
<li>AMD 的價格回調等於機會：大幅收益即將到來</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Privia Health Group 嗎？</h2>
<p>在你考慮 Privia Health Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 跟蹤華爾街頂級評級和表現最佳的研究分析師及其每日推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前立即購買……而 Privia Health Group 並不在名單上。</p>
<p>雖然 Privia Health Group 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

PRVA

<p>Privia Health Group（納斯達克代碼：PRVA）創下了 52 周的新高，達到 26.51 美元，收盤價為 26.02 美元，交易量為 83,139 股。分析師的評級意見不一，巴克萊將目標價上調至 22.00 美元，扎克斯則將評級上調至 “持有”。該股票的共識評級為 “適度買入”，目標價為 28.91 美元。機構投資者持有該股票的 94.48%。公司報告上個季度每股收益為 0.10 美元，收入為 2.1361 億美元</p>

<p>Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report)'s share price hit a new 52-week high during trading on Thursday . The stock traded as high as $26.51 and last traded at $26.02, with a volume of 83139 shares traded. The stock had previously closed at $25.02.</p>
<div class="lb-trans"><p>Privia Health Group, Inc. (NASDAQ:PRVA - 獲取免費報告) 的股價在週四的交易中創下了新的 52 周高點。該股最高交易價格為 26.51 美元，最後交易價格為 26.02 美元，交易量為 83139 股。該股此前收盤價為 25.02 美元。</p>
</div><p>Get <strong>Privia Health Group</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Privia Health Group</strong> 的提醒：</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>PRVA has been the subject of several recent analyst reports. Barclays raised their target price on Privia Health Group from $21.00 to $22.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Thursday, October 9th. Zacks Research raised Privia Health Group from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, August 19th. Citigroup reissued an &#34;outperform&#34; rating on shares of Privia Health Group in a research report on Friday, August 29th. Evercore ISI reduced their price objective on Privia Health Group from $30.00 to $28.00 and set an &#34;outperform&#34; rating for the company in a research report on Wednesday, July 9th. Finally, Piper Sandler cut their target price on Privia Health Group from $36.00 to $35.00 and set an &#34;overweight&#34; rating on the stock in a report on Monday, August 11th. Eleven research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $28.91.</p>
<div class="lb-trans"><p>PRVA 最近受到多份分析師報告的關注。巴克萊將 Privia Health Group 的目標價從 21.00 美元上調至 22.00 美元，並在 10 月 9 日的研究報告中給予該股 “持平” 評級。Zacks Research 在 8 月 19 日的研究報告中將 Privia Health Group 的評級從 “強烈賣出” 上調至 “持有”。花旗在 8 月 29 日的研究報告中重申了對 Privia Health Group 股票的 “跑贏大盤” 評級。Evercore ISI 在 7 月 9 日的研究報告中將 Privia Health Group 的目標價從 30.00 美元下調至 28.00 美元，並給予該公司 “跑贏大盤” 評級。最後，Piper Sandler 在 8 月 11 日的報告中將 Privia Health Group 的目標價從 36.00 美元下調至 35.00 美元，並對該股給予 “增持” 評級。共有 11 位研究分析師對該股給予 “買入” 評級，2 位給予 “持有” 評級，1 位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，共識目標價為 28.91 美元。</p>
</div><p><strong>Read Our Latest Analysis on PRVA</strong></p>
<div class="lb-trans"><p><strong>閲讀我們對 PRVA 的最新分析</strong></p>
</div><h2>Privia Health Group Stock Performance</h2>
<div class="lb-trans"><h2>Privia Health Group 股票表現</h2>
</div><p>The stock's 50-day moving average is $24.10 and its 200 day moving average is $22.76. The firm has a market cap of $3.18 billion, a P/E ratio of 236.70, a PEG ratio of 3.37 and a beta of 0.83.</p>
<div class="lb-trans"><p>該股的 50 日移動平均線為 24.10 美元，200 日移動平均線為 22.76 美元。該公司的市值為 31.8 億美元，市盈率為 236.70，PEG 比率為 3.37，貝塔值為 0.83。</p>
</div><p>Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. The firm had revenue of $213.61 million during the quarter. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%. On average, research analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current year.</p>
<div class="lb-trans"><p>Privia Health Group (NASDAQ:PRVA - 獲取免費報告) 最近於 6 月 7 日發佈了其財報。該公司報告季度每股收益（EPS）為 0.10 美元。該季度的收入為 2.1361 億美元。Privia Health Group 的股本回報率為 2.13%，淨利潤率為 0.78%。研究分析師平均預計 Privia Health Group, Inc.在當前年度將發佈 0.14 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Privia Health Group</h2>
<div class="lb-trans"><h2>機構投資者對 Privia Health Group 的看法</h2>
</div><p>Several hedge funds have recently bought and sold shares of the stock. Smartleaf Asset Management LLC increased its stake in Privia Health Group by 37.4% in the third quarter. Smartleaf Asset Management LLC now owns 12,398 shares of the company's stock valued at $303,000 after acquiring an additional 3,373 shares during the last quarter. Van Berkom &amp; Associates Inc. raised its holdings in shares of Privia Health Group by 30.1% during the third quarter. Van Berkom &amp; Associates Inc. now owns 3,774,565 shares of the company's stock valued at $93,987,000 after purchasing an additional 873,344 shares during the period. Thrivent Financial for Lutherans raised its holdings in shares of Privia Health Group by 8.0% during the third quarter. Thrivent Financial for Lutherans now owns 83,229 shares of the company's stock valued at $2,072,000 after purchasing an additional 6,130 shares during the period. Arizona State Retirement System increased its position in shares of Privia Health Group by 1.9% during the third quarter. Arizona State Retirement System now owns 28,835 shares of the company's stock worth $718,000 after acquiring an additional 524 shares in the last quarter. Finally, Summit Global Investments grew its position in Privia Health Group by 273.9% in the 3rd quarter. Summit Global Investments now owns 33,677 shares of the company's stock worth $839,000 after purchasing an additional 24,670 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>幾家對沖基金最近買入和賣出了該股的股份。Smartleaf Asset Management LLC 在第三季度將其在 Privia Health Group 的持股增加了 37.4%。Smartleaf Asset Management LLC 目前擁有該公司價值 303,000 美元的 12,398 股股票，在上個季度額外購買了 3,373 股。Van Berkom &amp; Associates Inc.在第三季度將其在 Privia Health Group 的持股增加了 30.1%。Van Berkom &amp; Associates Inc.目前擁有該公司價值 93,987,000 美元的 3,774,565 股股票，在此期間額外購買了 873,344 股。Thrivent Financial for Lutherans 在第三季度將其在 Privia Health Group 的持股增加了 8.0%。Thrivent Financial for Lutherans 目前擁有該公司價值 2,072,000 美元的 83,229 股股票，在此期間額外購買了 6,130 股。亞利桑那州退休系統在第三季度將其在 Privia Health Group 的持股增加了 1.9%。亞利桑那州退休系統目前擁有該公司價值 718,000 美元的 28,835 股股票，在上個季度額外購買了 524 股。最後，Summit Global Investments 在第三季度將其在 Privia Health Group 的持股增加了 273.9%。Summit Global Investments 目前擁有該公司價值 839,000 美元的 33,677 股股票，在上個季度額外購買了 24,670 股。94.48% 的股票目前由機構投資者和對沖基金持有。</p>
</div><h2>About Privia Health Group</h2>
<div class="lb-trans"><h2>關於 Privia Health Group</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.</p>
<div class="lb-trans"><p>Privia Health Group, Inc. 是一家在美國運營的全國性醫生賦能公司。該公司與醫療集團、健康計劃和健康系統合作，以優化醫生的實踐，提升患者體驗，並獎勵醫生在面對面和虛擬環境中提供護理。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Privia Health Group</li>
<li>Investing in the High PE Growth Stocks</li>
<li>Dutch Bros Beats Earnings for 11th Consecutive Quarter</li>
<li>Stock Average Calculator</li>
<li>From Dividends to Growth: Why These 3 Stocks Stand Out in 2025</li>
<li>Stock Sentiment Analysis: How it Works</li>
<li>AMD’s Price Pullback Equals Opportunity: The Big Gains Are Coming</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Privia Health Group 更好</li>
<li>投資於高市盈率成長股</li>
<li>Dutch Bros 連續第 11 個季度超出預期</li>
<li>股票平均計算器</li>
<li>從分紅到增長：為什麼這三隻股票在 2025 年脱穎而出</li>
<li>股票情緒分析：它是如何工作的</li>
<li>AMD 的價格回調等於機會：大幅收益即將到來</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Privia Health Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Privia Health Group 嗎？</h2>
</div><p>Before you consider Privia Health Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Privia Health Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟蹤華爾街頂級評級和表現最佳的研究分析師及其每日推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前立即購買……而 Privia Health Group 並不在名單上。</p>
</div><p>While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Privia Health Group 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Privia Health Group（NASDAQ:PRVA）創下 12 個月新高——你應該購買嗎？